Sponsor: Boston Medical Grayken Center for Addiction TTA, The Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA), Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS), The Opioid Response Network (ORN).
Description: “Protecting the Community and Serving Your Patient: The Importance of Buprenorphine” is Part 3 of 3 in the “Best Practices for Community Pharmacy-Based Care for Patients with Opioid Use Disorder” series. Part 3 describes the three medications that are mainly used for treating Opioid-Use Disorder, and dives deeper into buprenorphine prescribing and the pharmacy’s role in it.
Intended audience: This activity is intended for pharmacists and pharmacy technicians working as part of the healthcare team to treat patients for substance use disorder.
Description:
1. Describe the efficacy and safety of dispensing buprenorphine for opioid use disorder (OUD) treatment.
2. Explain an effective interaction between a pharmacy staff member and patient filling a prescription for buprenorphine.
2. Explain an effective interaction between a pharmacy staff member and patient filling a prescription for buprenorph
For more information and to register click here:
“Protecting the Community and Serving Your Patient: The Importance of Buprenorphine” is Part 3 of 3 in the “Best Practices for Community Pharmacy-Based Care for Patients with Opioid Use Disorder” series. Part 3 describes the three medications that are mainly used for treating Opioid-Use Disorder, and dives deeper into buprenorphine prescribing and the pharmacy’s role in it.
This is an open ended event
- Cost:
- FREE